UK's Cambridge Keen To Challenge US Counterpart With Biotech Start-Ups
CIC Raises £225m For Second Fund
Cambridge Innovation Capital partner Robert Tansley tells Scrip that the UK has "a really strong history of innovation in biological sciences and Cambridge has been at the forefront” but this has not equated to a substantial number of biotech companies “where we have lagged significantly behind the US."
